(TSX-V:MAPS),(Boerse Frankfurt – Freiverkehr:5D00),(OTC US:MAPPF),(Other OTC:MAPPF), GRAND JUNCTION, Colo., March 31, 2025 (GLOBE NEWSWIRE) — ProStar(R) Holdings Inc., (“ProStar(R)” or “the Company”) (TSXV: MAPS, OTCQX: MAPPF, FSE: 5D00), the developer of the PointMan(R) Precision Mapping Solutions(R), and Emlid Tech Kft., a European maker of high-precision GNSS equipment, have partnered to bring centimeter-level precision and cost-efficiency […]

(NasdaqGM:DJT),(NasdaqGM:DJTWW),(NYSE:DJT),(NYSE:DJTWW), DJT Stock Will Be First Listing on New Texas Exchange SARASOTA, Fla., March 31, 2025 (GLOBE NEWSWIRE) — Trump Media and Technology Group Corp. (Nasdaq: DJT) (“TMTG” or the “Company”), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, today will become the first new stock

(CNSX:BETR.CN),(Boerse Frankfurt – Freiverkehr:NPAU),(OTC US:BETRF),(Other OTC:BETRF),(Boerse Frankfurt – Freiverkehr:NPAU.F), VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company, is pleased to announce it has appointed Dr. Steven Sangha to its Board of Directors. Dr. Sangha

(NASDAQ:GRI), Company committed to building a robust global patent estate across its innovative pipeline of NKT cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases LA JOLLA, CA, March 31, 2025 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural

(NASDAQ:XAIR), GARDEN CITY, N.Y., March 31, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today announced that Vanderbilt University Medical Center (VUMC) has become the Company's first

(NASDAQ:TENX), CHAPEL HILL, N.C., March 31, 2025 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that the Company will present at the 24th Annual Needham Virtual Healthcare Conference, which is taking place virtually from

New data show the machine learning algorithms may be used to detect PCWP elevation, aiding in assessment of heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension (PH) subtypes Data was analyzed from patients signals collected using the CorVista System(R), the world's first non-invasive point-of-care solution currently approved for evaluating the presence of coronary

(NasdaqGM:VBTX), DALLAS, March 31, 2025 (GLOBE NEWSWIRE) — Veritex Holdings, Inc. (Nasdaq: VBTX) (“Veritex” or “the Company”), the parent holding company for Veritex Community Bank, today announced that its Board of Directors (the “Board”) authorized the extension of the stock buyback program (the “Stock Buyback Program”) through March 31, 2026, pursuant to which the Company

WALTHAM, Mass., March 31, 2025 (GLOBE NEWSWIRE) — FluidForm Bio(TM), a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Mike Graffeo, CEO and co-founder, will deliver a company overview and conduct one-on-one meetings at Venture Summit West, which is being held April 2-3 in Mountain View, CA. Details

(NasdaqGM:LFMD),(NasdaqGM:LFMDP), NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that management will be participating in the 24th Annual Needham Virtual Healthcare Conference taking place April 7-10, 2025. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.